COVID-19 vaccine claims scheme

More details are now available in relation to the Government’s no-fault COVID-19 vaccine compensation scheme that is being introduced following AMA lobbying. 

Patients who suffer a moderate to significant impact following an adverse reaction to an approved COVID-19 vaccine will have access to compensation from $1000.  

The Government’s COVID-19 Vaccine Claims Scheme is designed to compensate people who have suffered a recognised adverse event as a direct result of a Therapeutic Goods Administration (TGA) approved COVID-19 vaccine delivered through a Commonwealth Government approved program. 

The list of adverse effects for claims purposes under the scheme include the following clinical conditions that are diagnosed by a treating doctor and are included in the approved product information for the specific vaccine: 

  • anaphylactic reaction 
  • thrombosis with Thrombocytopenia Syndrome 
  • myocarditis 
  • pericarditis 
  • capillary leak syndrome 
  • demyelinating disorders including Guillain Barre Syndrome (GBS) 
  • Thrombocytopenia, including immune Thrombocytopenia, identified as a final diagnosis. 

Information about the scheme including policy documents and FAQs is located here

Related topics